IBRX
Immunitybio Inc
10.30$
+10.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -106,589.0% | -82,928.8% | -267,455.0% | -9,584.2% | -1,617.5% | -1,127.4% | -520.1% | -301.8% | -214.9% | -183.8% | -170.5% | -276.8% | -215.0% | |
| 19,559.8% | 3,283.5% | 11,387.5% | 420.8% | 72.7% | 54.8% | 23.2% | 14.7% | 12.3% | 10.1% | 9.9% | 17.1% | 12.7% | |
| 17,620.7% | 9,189.9% | 20,665.0% | 920.6% | 122.6% | 119.7% | 57.7% | 36.5% | 27.7% | 22.8% | 18.5% | 32.6% | 25.6% | |
| -5,211.0% | -18,524.5% | -9,732.5% | 512.2% | -164.6% | -143.6% | -133.4% | -21.0% | -38.5% | -37.6% | -1.1% | -1.8% | -17.0% | |
| 6,920.7% | 5,723.0% | 3,152.5% | 69.1% | 45.7% | 28.0% | 6.8% | 4.1% | 2.4% | 3.3% | 4.0% | 10.3% | 5.5% | |
| -19,062.2% | 1,618.0% | -89,055.0% | -4,917.9% | 1,065.1% | 130.2% | 25.0% | -61.1% | -565.7% | 113.8% | -71.6% | -271.5% | -186.1% | |
| 1,785.4% | – | 0.0% | – | – | – | 0.0% | – | – | – | – | – | – | |
| -1,785.4% | -1,123.7% | -9,667.5% | -369.3% | 63.3% | – | – | – | – | – | – | – | – | |
| – | – | – | – | -0.4% | 0.0% | 0.0% | 0.0% | 0.0% | 7.5% | 0.1% | 0.0% | 1.7% | |
| 289,636.6% | 144,272.7% | 25,562.5% | 14,221.0% | 255.2% | 1,415.9% | -5.9% | 654.0% | 541.2% | 143.4% | 506.6% | 523.7% | 434.7% | |
| 163,984.1% | 62,942.4% | -331,045.0% | -279.9% | -297.1% | 418.6% | -501.1% | 291.4% | -239.6% | 73.4% | 264.4% | -24.4% | 33.6% | |
| -113,509.8% | -88,651.8% | -270,607.5% | -9,653.4% | -1,663.2% | -1,155.4% | -526.9% | -305.9% | -217.3% | -187.2% | -174.5% | -287.2% | -220.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.